- Home
- UIS vs FHTX Comparison
UIS vs FHTX Comparison
Compare UIS & FHTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UIS
- FHTX
- Stock Information
- Founded
- UIS 1942
- FHTX 2015
- Country
- UIS United States
- FHTX United States
- Employees
- UIS N/A
- FHTX N/A
- Industry
- UIS EDP Services
- FHTX Medicinal Chemicals and Botanical Products
- Sector
- UIS Technology
- FHTX Health Care
- Exchange
- UIS Nasdaq
- FHTX Nasdaq
- Market Cap
- UIS 474.3M
- FHTX 513.7M
- IPO Year
- UIS N/A
- FHTX 2020
- Fundamental
- Price
- UIS $6.53
- FHTX $5.14
- Analyst Decision
- UIS
- FHTX Strong Buy
- Analyst Count
- UIS 0
- FHTX 5
- Target Price
- UIS N/A
- FHTX $13.80
- AVG Volume (30 Days)
- UIS 706.2K
- FHTX 197.3K
- Earning Date
- UIS 02-19-2025
- FHTX 11-04-2024
- Dividend Yield
- UIS N/A
- FHTX N/A
- EPS Growth
- UIS N/A
- FHTX N/A
- EPS
- UIS N/A
- FHTX N/A
- Revenue
- UIS $2,020,600,000.00
- FHTX $25,515,000.00
- Revenue This Year
- UIS $0.92
- FHTX N/A
- Revenue Next Year
- UIS $2.90
- FHTX $11.54
- P/E Ratio
- UIS N/A
- FHTX N/A
- Revenue Growth
- UIS 0.29
- FHTX N/A
- 52 Week Low
- UIS $3.32
- FHTX $2.70
- 52 Week High
- UIS $8.93
- FHTX $10.25
- Technical
- Relative Strength Index (RSI)
- UIS 39.54
- FHTX 27.35
- Support Level
- UIS $6.48
- FHTX $4.69
- Resistance Level
- UIS $7.08
- FHTX $5.70
- Average True Range (ATR)
- UIS 0.47
- FHTX 0.61
- MACD
- UIS -0.16
- FHTX -0.14
- Stochastic Oscillator
- UIS 2.04
- FHTX 16.24
About UIS Unisys Corporation New
Unisys Corp is engaged in the provision of technology solutions for clients across the government, financial services, and commercial markets. It operates through three business segments: Digital Workplace Solutions (DWS),Cloud, Applications & Infrastructure Solutions (CA&I), and Enterprise Computing Solutions (ECS). DWS provides solutions that transform digital workplaces securely and create exceptional end-user experiences. CA&I provides digital platform, applications and infrastructure solutions. ECS provides solutions that harness secure, continuous high-intensity computing and enable digital services through software-defined operating environments.
About FHTX Foghorn Therapeutics Inc.
Foghorn Therapeutics Inc is engaged in the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system. Its proprietary Gene Traffic Control platform gives an integrated, mechanistic understanding of how the various components of the chromatin regulatory system interact, allowing it to identify, validate, and potentially drug targets within the system. The company is developing FHD-286, a selective, allosteric ATPase inhibitor, and FHD-609, a protein degrader, to treat hematologic cancers and solid tumors.